Scancell receives approval to expand ModiFY cancer trial
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) has received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) to expand its ModiFY...
Source: proactiveinvestors.co.uk
Lindy Durrant News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Lindy Durrant. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Lindy Durrant Today - Breaking & Trending Today
Scancell : Interim Report 31st October 2023
CHIEF EXECUTIVE OFFICER'S STATEMENT I am pleased to report the Group's interim results for the six-month period ended 31 October 2023. During the period, Scancell...
Source: marketscreener.com
SCIB1 Plus Nivolumab/Ipilimumab Generates ORR of 85% in Advanced Unresectable Melanoma
SCIB1 plus nivolumab and ipilimumab elicited responses in patients with advanced, unresectable melanoma.
Source: onclive.com
Scancell Holdings doses first patient with iSCIB1+
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF), a developer of immunotherapies for cancer and infectious diseases, has reached a pivotal milestone in its...
Source: proactiveinvestors.co.uk
Investegate | Company Announcement
Investegate announcements from Scancell Attendance at Upcoming Conferences
Source: investegate.co.uk